1.94
price up icon0.52%   0.01
after-market Dopo l'orario di chiusura: 1.91 -0.03 -1.55%
loading
Precedente Chiudi:
$1.93
Aprire:
$1.92
Volume 24 ore:
127.51K
Relative Volume:
0.64
Capitalizzazione di mercato:
$57.37M
Reddito:
$80.97M
Utile/perdita netta:
$-78.31M
Rapporto P/E:
-0.175
EPS:
-11.0849
Flusso di cassa netto:
$-129.56M
1 W Prestazione:
+0.52%
1M Prestazione:
+8.38%
6M Prestazione:
+6.59%
1 anno Prestazione:
-21.14%
Intervallo 1D:
Value
$1.90
$1.95
Intervallo di 1 settimana:
Value
$1.88
$2.03
Portata 52W:
Value
$1.325
$2.6639

Fortress Biotech Inc Stock (FBIO) Company Profile

Name
Nome
Fortress Biotech Inc
Name
Telefono
781-652-4500
Name
Indirizzo
1111 KANE CONCOURSE, BAY HARBOR ISLANDS, NY
Name
Dipendente
101
Name
Cinguettio
@fortressbio
Name
Prossima data di guadagno
2024-11-12
Name
Ultimi documenti SEC
Name
FBIO's Discussions on Twitter

Confronta FBIO con altri titoli

Azioni Prezzo Cap. di mercato Reddito Reddito netto Flusso di cassa EPS
Biotechnology icon
FBIO
Fortress Biotech Inc
1.94 58.25M 80.97M -78.31M -129.56M -11.08
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
472.27 120.73B 11.10B -988.90M -1.26B -3.92
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
564.64 61.80B 14.09B 4.50B 2.96B 39.28
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
328.00 42.46B 2.35B -269.70M -75.39M -2.09
Biotechnology icon
ARGX
Argen X Se Adr
591.74 35.22B 2.58B 1.06B -1.28B 16.33
Biotechnology icon
ONC
Beone Medicines Ltd Adr
296.46 31.99B 3.81B -644.79M -669.77M -6.24

Fortress Biotech Inc Stock (FBIO) Upgrades & Downgrades

Data Azione Analista Modifica della valutazione
2024-03-15 Ripresa ROTH MKM Buy
2022-08-04 Iniziato Ladenburg Thalmann Buy
2020-10-02 Iniziato The Benchmark Company Buy
2019-12-18 Iniziato B. Riley FBR Buy
2018-02-28 Iniziato B. Riley FBR, Inc. Buy
2017-07-11 Iniziato Rodman & Renshaw Buy
2017-03-22 Iniziato JMP Securities Mkt Outperform
2016-10-03 Iniziato ROTH Capital Buy
Mostra tutto

Fortress Biotech Inc Borsa (FBIO) Ultime notizie

pulisher
Jul 23, 2025

What analysts say about Fortress Biotech Inc. stockSuperior capital gains - jammulinksnews.com

Jul 23, 2025
pulisher
Jul 23, 2025

How did Fortress Priority C's revenue and expenses perform in Q4 2024? - AInvest

Jul 23, 2025
pulisher
Jul 23, 2025

Is Fortress Biotech Inc. a good long term investmentOutstanding capital appreciation - Autocar Professional

Jul 23, 2025
pulisher
Jul 22, 2025

What drives Fortress Biotech Inc. stock priceSuperior portfolio returns - Autocar Professional

Jul 22, 2025
pulisher
Jul 22, 2025

Fortress Biotech Inc. Stock Analysis and ForecastFree Wealth Planning Blueprint - jammulinksnews.com

Jul 22, 2025
pulisher
Jul 22, 2025

How Fortress Biotech Inc. stock performs during market volatilityCapital Growth Picks - Newser

Jul 22, 2025
pulisher
Jul 19, 2025

Will Fortress Biotech Inc. stock split in the near futureVerified Return Tips - beatles.ru

Jul 19, 2025
pulisher
Jul 16, 2025

AstraZeneca’s Anselamimab Trial Shows Mixed Results - TipRanks

Jul 16, 2025
pulisher
Jul 15, 2025

Why Fortress Biotech Inc. stock attracts strong analyst attentionFree AI-Powered Stock Predictions - Newser

Jul 15, 2025
pulisher
Jul 15, 2025

What makes Fortress Biotech Inc. stock price move sharplyMarket Ready Callouts - Newser

Jul 15, 2025
pulisher
Jul 15, 2025

why fortress biotech inc. stock attracts strong analyst attentionProfessional Stock Screener - Newser

Jul 15, 2025
pulisher
Jul 14, 2025

Why Fast-paced Mover Fortress Biotech (FBIO) Is a Great Choice for Value Investors - Yahoo Finance

Jul 14, 2025
pulisher
Jul 14, 2025

Journey Medical Corporation Announces Expanded Payer Coverage for Emrosi™ - Stock Titan

Jul 14, 2025
pulisher
Jul 07, 2025

Mustang Bio Granted Orphan Drug Designation by U.S. FDA for - GlobeNewswire

Jul 07, 2025
pulisher
Jul 05, 2025

(FBIOP) Trading Advice - news.stocktradersdaily.com

Jul 05, 2025
pulisher
Jun 30, 2025

Fortress Biotech, Inc.(NasdaqCM: FBIO) dropped from Russell 3000E Growth Index - MarketScreener

Jun 30, 2025
pulisher
Jun 24, 2025

(FBIOP) Investment Analysis and Advice - news.stocktradersdaily.com

Jun 24, 2025
pulisher
Jun 24, 2025

Journey Medical to Join Russell 2000® and Russell 3000® Indexes - GlobeNewswire

Jun 24, 2025
pulisher
Jun 23, 2025

Fortress Biotech shareholders approve board proposals at annual meeting - Investing.com

Jun 23, 2025
pulisher
Jun 20, 2025

Journey Medical Corporation Announces Emrosi™ Data Analysis - GlobeNewswire

Jun 20, 2025
pulisher
Jun 19, 2025

Despite Fast-paced Momentum, Fortress Biotech (FBIO) Is Still a Bargain Stock - Nasdaq

Jun 19, 2025
pulisher
Jun 14, 2025

How To Trade (FBIOP) - news.stocktradersdaily.com

Jun 14, 2025
pulisher
Jun 13, 2025

Two Sigma Investments LP Invests $109,000 in Fortress Biotech, Inc. (NASDAQ:FBIO) - Defense World

Jun 13, 2025
pulisher
Jun 09, 2025

Journey Medical Corporation Announces Emrosi™ Featured on “The Balancing Act” Airing on Lifetime TV - GlobeNewswire

Jun 09, 2025
pulisher
Jun 09, 2025

Jane Street Group LLC Takes Position in Fortress Biotech, Inc. (NASDAQ:FBIO) - Defense World

Jun 09, 2025
pulisher
Jun 05, 2025

SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Fortress Biotech, Inc. of Class Action Lawsuit and Upcoming Deadline – FBIO - ACCESS Newswire

Jun 05, 2025
pulisher
Jun 03, 2025

Fortress Biotech (FBIO) Is Attractively Priced Despite Fast-paced Momentum - Yahoo Finance

Jun 03, 2025
pulisher
Jun 01, 2025

Checkpoint Therapeutics, Inc.(NasdaqCM: CKPT) dropped from S&P TMI Index - marketscreener.com

Jun 01, 2025
pulisher
May 30, 2025

Fortress Biotech Announces Closing of Sale of Subsidiary Checkpo - GuruFocus

May 30, 2025
pulisher
May 30, 2025

Fortress Biotech Announces Sale of Subsidiary Checkpoint Therapeutics - citybiz

May 30, 2025
pulisher
May 30, 2025

Sun Pharmaceutical Industries Completes Acquisition Of Checkpoint Therapeutics - marketscreener.com

May 30, 2025
pulisher
May 30, 2025

Fortress Biotech Closes Sale of Checkpoint Therapeutics Unit - marketscreener.com

May 30, 2025
pulisher
May 30, 2025

Fortress Biotech Announces Closing of Sale of Subsidiary Checkpoint Therapeutics | FBIO Stock News - GuruFocus

May 30, 2025
pulisher
May 30, 2025

Fortress Biotech Announces Closing of Sale of Subsidiary Checkpoint Therapeutics - GlobeNewswire

May 30, 2025
pulisher
May 30, 2025

Fortress Biotech, Inc. Announces Acquisition of Checkpoint Therapeutics by Sun Pharmaceutical Industries Limited - Nasdaq

May 30, 2025
pulisher
May 30, 2025

Fortress Biotech Announces Closing of Sale of Subsidiary Checkpoint Therapeutics - Benzinga

May 30, 2025
pulisher
May 30, 2025

Fortress Biotech Cashes In: $28M Upfront Plus Royalties in Strategic Checkpoint Sale to Sun Pharma - Stock Titan

May 30, 2025
pulisher
May 29, 2025

Checkpoint Therapeutics shareholders approve Sun Pharma merger By Investing.com - Investing.com India

May 29, 2025
pulisher
May 29, 2025

One Fortress Biotech Insider Raised Stake By 26% In Previous Year - simplywall.st

May 29, 2025

Fortress Biotech Inc Azioni (FBIO) Dati Finanziari

Reddito

loading

Reddito netto

loading

Flusso di cassa

loading

EPS

loading

Fortress Biotech Inc Azioni (FBIO) insider trading

Commercio interno Relazione Data Transazione Costo #Azioni Valore ($) #Azioni Totale
ROSENWALD LINDSAY A MD
PRESIDENT, CEO & CHAIRMAN
Sep 23 '24
Buy
1.84
763,359
1,404,581
3,657,264
$23.63
price up icon 3.32%
$36.59
price up icon 1.61%
$103.52
price up icon 0.08%
$27.57
price down icon 1.57%
$114.57
price down icon 0.03%
biotechnology ONC
$296.46
price up icon 0.55%
Capitalizzazione:     |  Volume (24 ore):